Megan Madonna
Duke University
H-index: 7
North America-United States
Top articles of Megan Madonna
Optical imaging reveals chemotherapy-induced metabolic reprogramming of residual disease and recurrence
Science Advances
2024/4/5
Development of a multi-scale imaging tool to quantify in vivo metabolic heterogeneity
2024/3/12
Metabolic imaging as a tool to characterize chemoresistance and guide therapy in Triple-Negative Breast Cancer (TNBC)
2023/10/2
In Vivo Metabolic Imaging Reveals Mitochondrial Membrane Potential Reprogramming During Residual Disease Following Chemotherapy
2020/4/20
Development of a multi-scale platform to quantify metabolic heterogeneity in vivo
2023/4/24
Community-Centered Design Thinking as a Scalable STEM Learning Intervention.
Advances in Engineering Education
2023/4/1
Abstract P6-01-01: Validation of an Optical Imaging Platform to Identify Metabolic Vulnerabilities in Chemo-Resistant and Sensitive Tumors
Cancer Research
2023/3/1
Megan Madonna
H-Index: 5
Nimmi Ramanujam
H-Index: 31
[18F] Fluoro-DCP, a first generation PET radiotracer for monitoring protein sulfenylation in vivo
Redox Biology
2022/2/1
In vivo metabolic imaging identifies lipid vulnerability in a preclinical model of Her2+/Neu breast cancer residual disease and recurrence
NPJ Breast Cancer
2022/9/26
Optical imaging captures chemo-induced metabolic reprogramming during disease regression
Cancer Research
2022/6/15
Megan Madonna
H-Index: 5
Editorial overview: Biomedical engineering and women's health: Breaking new ground in gender-and sex-specific research
2022/6/1
Megan Madonna
H-Index: 5
A Spectroscopic Technique to Simultaneously Characterize Fatty Acid Uptake, Mitochondrial Activity, Vascularity, and Oxygen Saturation for Longitudinal Studies In Vivo
Metabolites
2022/4/19
In vivo optical metabolic imaging of long-chain fatty acid uptake in orthotopic models of triple-negative breast cancer
Cancers
2021/1/5
[18F]DCP, First Generation PET Radiotracer for Diagnosis of Radiation Resistant Head and Neck Cancer
bioRxiv
2020/4/30
Harnessing Optical Imaging for Assessing Metabolic Reprogramming in Breast Cancer
2020